Cita APA

Nicolás Morala, J., Mascaraque Checa, M., Gallego Rentero, M., Barahona, A., Abarca-Lachen, E., Carrasco Cerro, E., . . . Juarranz de la Fuente, Á. (2024). The m-TORC1 inhibitor Sirolimus increases the effectiveness of Photodynamic therapy in the treatment of cutaneous Squamous Cell Carcinoma, impairing NRF2 antioxidant signaling.

Citación estilo Chicago

Nicolás Morala, Jimena, Marta Mascaraque Checa, María Gallego Rentero, Andrea Barahona, Edgar Abarca-Lachen, Elisa Carrasco Cerro, Yolanda Gilaberte, Salvador González, y Ángeles Juarranz de la Fuente. The M-TORC1 Inhibitor Sirolimus Increases the Effectiveness of Photodynamic Therapy in the Treatment of Cutaneous Squamous Cell Carcinoma, Impairing NRF2 Antioxidant Signaling. 2024.

Cita MLA

Nicolás Morala, Jimena, et al. The M-TORC1 Inhibitor Sirolimus Increases the Effectiveness of Photodynamic Therapy in the Treatment of Cutaneous Squamous Cell Carcinoma, Impairing NRF2 Antioxidant Signaling. 2024.